dextroamphetamine has been researched along with fluoxetine in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (40.74) | 18.7374 |
| 1990's | 8 (29.63) | 18.2507 |
| 2000's | 3 (11.11) | 29.6817 |
| 2010's | 4 (14.81) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Arunotayanun, W; Dalley, JW; Gibbons, S; Huang, XP; Iversen, L; Roth, BL; Setola, V; Treble, R | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Choi, Y; Raymer, BK | 1 |
| Tessel, RE; Tyler, TD | 1 |
| Clineschmidt, BV; McGuffin, JC | 1 |
| Asin, KE; Bednarz, L; Davis, JD | 1 |
| Dewan, M; Ghaly, N; Gupta, S | 1 |
| Linet, LS | 1 |
| Flood, JF; Morley, JE | 1 |
| Maickel, RP; Spratto, GR; Tocco, DR | 1 |
| Boja, JW; Schechter, MD | 1 |
| Goldberg, LI; Kamien, JB; Woolverton, WL | 1 |
| Jackson, DM; Jenkins, OF | 1 |
| Homan, HD; Ziance, RJ | 1 |
| Fuller, RW; Perry, KW; Ricaurte, GA; Schuster, CR; Seiden, LS | 1 |
| Leccese, AP; Lyness, WH | 1 |
| Rabkin, JG; Rabkin, R; Wagner, G | 1 |
| Benjamin, S; Connor, DF; Ozbayrak, KR | 1 |
| Hong, E; Meneses, A | 1 |
| Andersen, SL; Klein, DA; Teicher, MH; Wallace, P | 1 |
| Dogin, JW; Findling, RL | 1 |
| Gudelsky, GA; Shankaran, M; Yamamoto, BK | 1 |
| Dlaboga, D; Dziedzicka-Wasylewska, M; Maj, J; Rogoz, Z; Skuza, G | 1 |
| Baumann, MH; Rothman, RB; Zolkowska, D | 1 |
| Bifone, A; Gozzi, A; Schwarz, AJ | 1 |
| Bonaventure, P; Dugovic, C; Dvorak, C; Liu, C; Lord, B; Lovenberg, T; Wang, L; White, A; Yun, S | 1 |
4 review(s) available for dextroamphetamine and fluoxetine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Sleep modulating agents.
Topics: Animals; Humans; Sleep; Sleep Aids, Pharmaceutical; Sleep Wake Disorders; Wakefulness-Promoting Agents | 2019 |
Hypothesis: bromocriptine lacks intrinsic dopamine receptor stimulating properties.
Topics: Adenylyl Cyclases; alpha-Methyltyrosine; Animals; Bromocriptine; Desipramine; Dextroamphetamine; Drug Interactions; Fluoxetine; Humans; Methyltyrosines; Mice; Motor Activity; Nialamide; Nomifensine; Nucleus Accumbens; Rats; Receptors, Dopamine; Reserpine; Stereotyped Behavior | 1985 |
Psychopharmacology of ADHD: children and adolescents.
Topics: Adolescent; Age Factors; Amphetamines; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Cyclohexanols; Dextroamphetamine; Drug Administration Schedule; Fluoxetine; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Pemoline; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
1 trial(s) available for dextroamphetamine and fluoxetine
| Article | Year |
|---|---|
Effects of fluoxetine on mood and immune status in depressed patients with HIV illness.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Affect; Aged; CD4-Positive T-Lymphocytes; Depressive Disorder; Dextroamphetamine; Drug Therapy, Combination; Female; Fluoxetine; HIV Seropositivity; Humans; Immunity; Leukocyte Count; Male; Middle Aged; Personality Inventory; Psychiatric Status Rating Scales; Treatment Outcome | 1994 |
22 other study(ies) available for dextroamphetamine and fluoxetine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.
Topics: Allyl Compounds; HEK293 Cells; Humans; Indoles; Magnetic Resonance Spectroscopy; Molecular Conformation; Propylamines; Protein Binding; Psychotropic Drugs; Receptors, Serotonin; Serotonin Receptor Agonists; Spectrophotometry, Ultraviolet; Tryptamines | 2013 |
Amphetamine's locomotor-stimulant and noreprinephrine-releasing effects: evidence for selective antagonism by nisoxetine.
Topics: Animals; Brain Chemistry; Dextroamphetamine; Fluoxetine; Humans; Male; Mice; Mice, Inbred ICR; Motor Activity; Neurotransmitter Agents; Norepinephrine; Phenyl Ethers; Propylamines; Stereotyped Behavior | 1979 |
Pharmacological differentiation of the central 5-hydroxytryptamine-like actions of MK-212 (6-chloro-2[1-piperazinyl]-pyrazine),p-methoxyamphetamine and fenfluramine in an in vivo model system.
Topics: Amphetamines; Animals; Dextroamphetamine; Drug Interactions; Fenclonine; Fenfluramine; Fluoxetine; In Vitro Techniques; Male; Metergoline; Muscle Contraction; Piperazines; Pyrazines; Rats; Serotonin; Time Factors | 1978 |
Differential effects of serotonergic and catecholaminergic drugs on ingestive behavior.
Topics: Animals; Dextroamphetamine; Eating; Fenfluramine; Fluoxetine; Male; Parasympathomimetics; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists | 1992 |
Augmenting fluoxetine with dextroamphetamine to treat refractory depression.
Topics: Adult; Child of Impaired Parents; Depressive Disorder; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Recurrence | 1992 |
Treatment of a refractory depression with a combination of fluoxetine and d-amphetamine.
Topics: Adult; Depressive Disorder; Dextroamphetamine; Drug Combinations; Fluoxetine; Humans; Male; Recurrence | 1989 |
An investigation of tolerance to the actions of leptogenic and anorexigenic drugs in mice.
Topics: Amphetamine; Animals; Appetite Depressants; Body Weight; Calcitonin; Dextroamphetamine; Drug Tolerance; Eating; Fluoxetine; Mice; Morphine; Naltrexone; Neurotransmitter Agents | 1987 |
Differential analgetic actions of amphetamine enantiomers in the mouse: a drug-drug interaction study.
Topics: Amphetamine; Analgesics; Animals; Dextroamphetamine; Dopamine; Drug Interactions; Fenclonine; Fluoxetine; Male; Metergoline; Mice; Morphine; Naloxone; Norepinephrine; Pimozide; Serotonin; Stereoisomerism | 1985 |
Lack of generalization of nisoxetine with amphetamine in the rat.
Topics: Animals; Conditioning, Operant; Dextroamphetamine; Discrimination, Psychological; Dose-Response Relationship, Drug; Fluoxetine; Male; Norepinephrine; Rats; Rats, Inbred Strains; Reference Values | 1988 |
Pharmacological analysis of the apomorphine discriminative stimulus in rhesus monkeys.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Cocaine; Conditioning, Operant; Dextroamphetamine; Discrimination Learning; Domperidone; Dose-Response Relationship, Drug; Female; Fluoxetine; Macaca mulatta; Male; Physostigmine; Piribedil; Quipazine; Sodium Chloride | 1987 |
The effects of d-amphetamine and potassium on serotonin release and metabolism in rat cerebral cortex tissue.
Topics: Animals; Brain; Calcium; Dextroamphetamine; Fluoxetine; Hydroxyindoleacetic Acid; In Vitro Techniques; Male; Monoamine Oxidase; Potassium; Rats; Serotonin | 1981 |
Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine.
Topics: Animals; Caudate Nucleus; Dextroamphetamine; Dopamine; Drug Interactions; Fluoxetine; Male; Methamphetamine; Propylamines; Putamen; Rats; Rats, Inbred Strains; Serotonin | 1983 |
The effects of putative 5-hydroxytryptamine receptor active agents on D-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions.
Topics: 5,7-Dihydroxytryptamine; Animals; Cyproheptadine; Dextroamphetamine; Fluoxetine; Humans; Male; Medial Forebrain Bundle; Methysergide; Neural Pathways; Quipazine; Rats; Rats, Inbred Strains; Serotonin; Substance-Related Disorders; Tryptophan | 1984 |
Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment.
Topics: Antipsychotic Agents; Dextroamphetamine; Diphenhydramine; Fluoxetine; Humans; Male; Mental Disorders; Movement Disorders; Perphenazine; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome; Videotape Recording | 1995 |
Effect of fluoxetine on learning and memory involves multiple 5-HT systems.
Topics: Animals; Cholinergic Antagonists; Conditioning, Operant; Dextroamphetamine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluoxetine; Injections, Intraperitoneal; Learning; Male; Memory; Parasympatholytics; Rats; Rats, Wistar; Scopolamine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sympathomimetics; Synaptic Transmission | 1995 |
Development of an animal model of fluoxetine akathisia.
Topics: Akathisia, Drug-Induced; Animals; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Fluoxetine; Locomotion; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 1995 |
Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine.
Topics: Animals; Carrier Proteins; Corpus Striatum; Dextroamphetamine; Dopamine Agents; Fluoxetine; Hydroxybenzoates; Hydroxyl Radical; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Salicylic Acid; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Time Factors | 1999 |
Effect of repeated treatment with tianeptine and fluoxetine on central dopamine D(2) /D(3) receptors.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Autoradiography; Brain Chemistry; Caudate Nucleus; Dextroamphetamine; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Fluoxetine; Islands of Calleja; Male; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Tetrahydronaphthalenes; Thiazepines | 2002 |
Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease.
Topics: Amphetamines; Animals; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Electrochemistry; Fluoxetine; Heart Diseases; Hydroxyindoleacetic Acid; Indicators and Reagents; Lung Diseases; Male; Methamphetamine; Microdialysis; Mitogens; Muscle, Smooth, Vascular; N-Methyl-3,4-methylenedioxyamphetamine; Phentermine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Stimulation, Chemical | 2006 |
Community structure in networks of functional connectivity: resolving functional organization in the rat brain with pharmacological MRI.
Topics: Algorithms; Animals; Brain; Brain Mapping; Dextroamphetamine; Dopamine Uptake Inhibitors; Fluoxetine; Magnetic Resonance Imaging; Male; Neural Pathways; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2009 |
Putative role of GPR139 on sleep modulation using pharmacological and genetic rodent models.
Topics: Animals; Citalopram; Dextroamphetamine; Dopamine; Fluoxetine; Male; Mice, Inbred C57BL; Mice, Knockout; Models, Animal; Nerve Tissue Proteins; Norepinephrine; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Serotonin; Sleep | 2020 |